Rebecca Weir

Rebecca is the co-founder and Director of Business Development at Isansys. Before Isansys she was responsible for the setting up and managing clinical trials at Toumaz (now Sensium) and worked closely with a number of hospitals, project leaders, ethics committees and clinical and nursing staff. Rebecca has an MSc in Molecular and Cellular Biology from the University of Glasgow and worked on the possible role of transcription factors in tumour cells while undertaking doctoral studies at Oxford University.